Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac for Pain Control in Intravitreal Injections
NCT04343222Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bromfenac sodium, sponsored by University of Wisconsin–Madison. Started Jun 2019; status: completed.
02
Drugs
bromfenac sodium
Beyond the preview
Go deeper on NCT04343222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343222.